CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company mainly focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid...
CARsgen Therapeutics Holdings Limited , a company mainly focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced...